Kura Oncology Statistics
NASDAQ: KURAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
10.60+0.08 (+0.76%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Kura Oncology by the numbers
Kura Oncology has a market capitalization of $943.0 million based on 88.96M shares outstanding. With trailing EPS of $-3.37, Kura Oncology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.7% below its 50-day average and 8.0% above its 200-day average.
Average daily trading volume is 1.78M shares, or about $18.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
KURA valuation vs. peer median
| Metric | KURA | Peer median | Difference |
|---|---|---|---|
| Market cap | $942.98M | $918.83M | +3% |
| Avg. volume | 1.78M | 773.84K | +130% |
Peer median across 8 companies: ALMS, MLTX, RIGL, ANRO, JBIO, SPTX, CRVS, CYRX.
Valuation
- Market cap
- $942.98M
- Price / sales (latest FY)
- 13.97
- EPS (TTM)
- $-3.37
- Shares outstanding
- 88.96M
Price and trading
- Previous close
- 10.52
- Open
- 10.42
- Day range
- 10.38 – 10.68
- 52-week range
- 7.36 – 13.90
- 52-week change
- +3.41%
- Beta
- —
- Volume
- 1.47M
- Average volume
- 1.78M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 942.98M
- Forward Pe
- -4.51
- Eps
- -3.37
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 13.90
- Week52 Low
- 7.36
- Avg Volume
- 1.78M
- Shares Outstanding
- 88.96M
- Ma50
- 11.24
- Ma200
- 9.82
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -23.74%
- Pct From52w Low
- 44.06%